Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 190K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Chaudhury, C. Articles by Anderson, C. L. Search for Related Content PubMed PubMed Citation Articles by Chaudhury, C. Articles by Anderson, C. L. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Social Bookmarking                      What's this?

¹ Department of Internal Medicine, The Ohio State University, Columbus, OH 43210
² Department of Physiology and Cell Biology, The Ohio State University, Columbus, OH 43210
³ Department of Pharmacy, The Ohio State University, Columbus, OH 43210
⁴ Department of Statistics, The Ohio State University, Columbus, OH 43210
⁵ The Jackson Laboratory, Bar Harbor, ME 04609

Address correspondence to Dr. Clark Anderson, Department of Internal Medicine, The Ohio State University, 415 HLRI, 473 West 12 Ave., Columbus, OH 43210. Phone: 614-247-7654; Fax: 614-247-7669; E-mail: anderson.48{at}osu.edu

The inverse relationship between serum albumin concentration and its half-life suggested to early workers that albumin would be protected from a catabolic fate by a receptor-mediated mechanism much like that proposed for IgG. We show here that albumin binds FcRn in a pH dependent fashion, that the lifespan of albumin is shortened in FcRn-deficient mice, and that the plasma albumin concentration of FcRn-deficient mice is less than half that of wild-type mice. These results affirm the hypothesis that the major histocompatibility complex–related Fc receptor protects albumin from degradation just as it does IgG, prolonging the half-lives of both.

Key Words: antibody • transport • half-life • pharmacokinetics • metabolism

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Miller, W. G., Bruns, D. E., Hortin, G. L., Sandberg, S., Aakre, K. M., McQueen, M. J., Itoh, Y., Lieske, J. C., Seccombe, D. W., Jones, G., Bunk, D. M., Curhan, G. C., Narva, A. S., on behalf of the National Kidney Disease Education, (2009). Current Issues in Measurement and Reporting of Urinary Albumin Excretion. Clin. Chem. 55: 24-38 [Abstract] [Full Text]  
• Ye, L., Liu, X., Rout, S. N., Li, Z., Yan, Y., Lu, L., Kamala, T., Nanda, N. K., Song, W., Samal, S. K., Zhu, X. (2008). The MHC Class II-Associated Invariant Chain Interacts with the Neonatal Fc{gamma} Receptor and Modulates Its Trafficking to Endosomal/Lysosomal Compartments. J. Immunol. 181: 2572-2585 [Abstract] [Full Text]  
• Qiao, S.-W., Kobayashi, K., Johansen, F.-E., Sollid, L. M., Andersen, J. T., Milford, E., Roopenian, D. C., Lencer, W. I., Blumberg, R. S. (2008). Dependence of antibody-mediated presentation of antigen on FcRn. Proc. Natl. Acad. Sci. USA 105: 9337-9342 [Abstract] [Full Text]  
• Liu, X., Ye, L., Bai, Y., Mojidi, H., Simister, N. E., Zhu, X. (2008). Activation of the JAK/STAT-1 Signaling Pathway by IFN-{gamma} Can Down-Regulate Functional Expression of the MHC Class I-Related Neonatal Fc Receptor for IgG. J. Immunol. 181: 449-463 [Abstract] [Full Text]  
• Kim, J., Bronson, C. L., Wani, M. A., Oberyszyn, T. M., Mohanty, S., Chaudhury, C., Hayton, W. L., Robinson, J. M., Anderson, C. L. (2008). {beta}2-Microglobulin Deficient Mice Catabolize IgG More Rapidly Than FcRn-{alpha}-Chain Deficient Mice. Exp. Biol. Med. 233: 603-609 [Abstract] [Full Text]  
• Holt, L. J., Basran, A., Jones, K., Chorlton, J., Jespers, L. S., Brewis, N. D., Tomlinson, I. M. (2008). Anti-serum albumin domain antibodies for extending the half-lives of short lived drugs. Protein Eng Des Sel 21: 283-288 [Abstract] [Full Text]  
• Tesar, D. B., Cheung, E. J., Bjorkman, P. J. (2008). The Chicken Yolk Sac IgY Receptor, a Mammalian Mannose Receptor Family Member, Transcytoses IgY across Polarized Epithelial Cells. Mol. Biol. Cell 19: 1587-1593 [Abstract] [Full Text]  
• Stork, R., Zettlitz, K. A., Muller, D., Rether, M., Hanisch, F.-G., Kontermann, R. E. (2008). N-Glycosylation as Novel Strategy to Improve Pharmacokinetic Properties of Bispecific Single-chain Diabodies. J. Biol. Chem. 283: 7804-7812 [Abstract] [Full Text]  
• Mezo, A. R., McDonnell, K. A., Hehir, C. A. T., Low, S. C., Palombella, V. J., Stattel, J. M., Kamphaus, G. D., Fraley, C., Zhang, Y., Dumont, J. A., Bitonti, A. J. (2008). Reduction of IgG in nonhuman primates by a peptide antagonist of the neonatal Fc receptor FcRn. Proc. Natl. Acad. Sci. USA 105: 2337-2342 [Abstract] [Full Text]  
• Akilesh, S., Huber, T. B., Wu, H., Wang, G., Hartleben, B., Kopp, J. B., Miner, J. H., Roopenian, D. C., Unanue, E. R., Shaw, A. S. (2008). From the Cover: Podocytes use FcRn to clear IgG from the glomerular basement membrane. Proc. Natl. Acad. Sci. USA 105: 967-972 [Abstract] [Full Text]  
• Akilesh, S., Christianson, G. J., Roopenian, D. C., Shaw, A. S. (2007). Neonatal FcR Expression in Bone Marrow-Derived Cells Functions to Protect Serum IgG from Catabolism. J. Immunol. 179: 4580-4588 [Abstract] [Full Text]  
• Liu, X., Ye, L., Christianson, G. J., Yang, J.-Q., Roopenian, D. C., Zhu, X. (2007). NF-{kappa}B Signaling Regulates Functional Expression of the MHC Class I-Related Neonatal Fc Receptor for IgG via Intronic Binding Sequences. J. Immunol. 179: 2999-3011 [Abstract] [Full Text]  
• Cooper, J. C., Dealtry, G. B., Ahmed, M. A., Arck, P. C., Klapp, B. F., Blois, S. M., Fernandez, N. (2007). An Impaired Breeding Phenotype in Mice with a Genetic Deletion of Beta-2 Microglobulin and Diminished MHC Class I Expression: Role in Reproductive Fitness. Biol. Reprod. 77: 274-279 [Abstract] [Full Text]  
• Muller, D., Karle, A., Meissburger, B., Hofig, I., Stork, R., Kontermann, R. E. (2007). Improved Pharmacokinetics of Recombinant Bispecific Antibody Molecules by Fusion to Human Serum Albumin. J. Biol. Chem. 282: 12650-12660 [Abstract] [Full Text]  
• Dennis, M. S., Jin, H., Dugger, D., Yang, R., McFarland, L., Ogasawara, A., Williams, S., Cole, M. J., Ross, S., Schwall, R. (2007). Imaging Tumors with an Albumin-Binding Fab, a Novel Tumor-Targeting Agent. Cancer Res. 67: 254-261 [Abstract] [Full Text]  
• Petkova, S. B., Akilesh, S., Sproule, T. J., Christianson, G. J., Al Khabbaz, H., Brown, A. C., Presta, L. G., Meng, Y. G., Roopenian, D. C. (2006). Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease. Int Immunol 18: 1759-1769 [Abstract] [Full Text]  
• Vidarsson, G., Stemerding, A. M., Stapleton, N. M., Spliethoff, S. E., Janssen, H., Rebers, F. E., de Haas, M., van de Winkel, J. G. (2006). FcRn: an IgG receptor on phagocytes with a novel role in phagocytosis. Blood 108: 3573-3579 [Abstract] [Full Text]  
• Stan, R. V. (2006). Endocytosis pathways in endothelium: how many?. Am. J. Physiol. Lung Cell. Mol. Physiol. 290: L806-L808 [Full Text]  
• Kacskovics, I., Kis, Z., Mayer, B., West, A. P. Jr, Tiangco, N. E., Tilahun, M., Cervenak, L., Bjorkman, P. J., Goldsby, R. A., Szenci, O., Hammarstrom, L. (2006). FcRn mediates elongated serum half-life of human IgG in cattle. Int Immunol 18: 525-536 [Abstract] [Full Text]  
• Wani, M. A., Haynes, L. D., Kim, J., Bronson, C. L., Chaudhury, C., Mohanty, S., Waldmann, T. A., Robinson, J. M., Anderson, C. L. (2006). Familial hypercatabolic hypoproteinemia caused by deficiency of the neonatal Fc receptor, FcRn, due to a mutant beta2-microglobulin gene. Proc. Natl. Acad. Sci. USA 103: 5084-5089 [Abstract] [Full Text]  
• Crowley, H., Alroy, J., Sproule, T. J., Roopenian, D., Huber, B. T. (2006). The MHC class I-related FcRn ameliorates murine Lyme arthritis. Int Immunol 18: 409-414 [Abstract] [Full Text]  
• Kim, J., Bronson, C. L., Hayton, W. L., Radmacher, M. D., Roopenian, D. C., Robinson, J. M., Anderson, C. L. (2006). Albumin turnover: FcRn-mediated recycling saves as much albumin from degradation as the liver produces. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G352-G360 [Abstract] [Full Text]  
• Mehta, D., Malik, A. B. (2006). Signaling Mechanisms Regulating Endothelial Permeability. Physiol. Rev. 86: 279-367 [Abstract] [Full Text]  
• Takizawa, T., Anderson, C. L., Robinson, J. M. (2005). A Novel Fc{gamma}R-Defined, IgG-Containing Organelle in Placental Endothelium. J. Immunol. 175: 2331-2339 [Abstract] [Full Text]  
• Zhou, J, Pop, L M, Ghetie, V (2005). Hypercatabolism of IgG in mice with lupus-like syndrome. Lupus 14: 458-466 [Abstract]  
• Newton, E. E., Wu, Z., Simister, N. E. (2005). Characterization of basolateral-targeting signals in the neonatal Fc receptor. J. Cell Sci. 118: 2461-2469 [Abstract] [Full Text]  
• Koltun, M., Nikolovski, J., Strong, K., Nikolic-Paterson, D., Comper, W. D. (2005). Mechanism of hypoalbuminemia in rodents. Am. J. Physiol. Heart Circ. Physiol. 288: H1604-H1610 [Abstract] [Full Text]  
• Peeples, E. S., Schopfer, L. M., Duysen, E. G., Spaulding, R., Voelker, T., Thompson, C. M., Lockridge, O. (2005). Albumin, a New Biomarker of Organophosphorus Toxicant Exposure, Identified by Mass Spectrometry. Toxicol Sci 83: 303-312 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS